Cambridge Investment Research Advisors’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-140,331
| Closed | -$13.9M | – | 2520 |
|
|
2019
Q3 | $13.9M | Buy |
140,331
+107,440
| +327% | +$10.2M | 0.12% | 173 |
|
|
2019
Q2 | $3.04M | Sell |
32,891
-9,997
| -23% | -$949K | 0.03% | 563 |
|
|
2019
Q1 | $4.05M | Sell |
42,888
-13,451
| -24% | -$1.18M | 0.04% | 441 |
|
|
2018
Q4 | $3.61M | Buy |
56,339
+12,975
| +30% | +$958K | 0.04% | 431 |
|
|
2018
Q3 | $3.88M | Buy |
43,364
+2,020
| +5% | +$179K | 0.04% | 445 |
|
|
2018
Q2 | $3.28M | Sell |
41,344
-4,329
| -9% | -$359K | 0.03% | 472 |
|
|
2018
Q1 | $4.08M | Buy |
45,673
+8,323
| +22% | +$799K | 0.05% | 375 |
|
|
2017
Q4 | $3.9M | Buy |
37,350
+2,459
| +7% | +$277K | 0.05% | 373 |
|
|
2017
Q3 | $5.09M | Buy |
34,891
+452
| +1% | +$61.6K | 0.07% | 281 |
|
|
2017
Q2 | $4.47M | Buy |
34,439
+3,654
| +12% | +$448K | 0.07% | 281 |
|
|
2017
Q1 | $3.83M | Sell |
30,785
-5,582
| -15% | -$668K | 0.07% | 285 |
|
|
2016
Q4 | $4.21M | Buy |
36,367
+98
| +0.3% | +$10.9K | 0.08% | 240 |
|
|
2016
Q3 | $3.79M | Buy |
36,269
+1,352
| +4% | +$146K | 0.07% | 270 |
|
|
2016
Q2 | $3.44M | Sell |
34,917
-1,923
| -5% | -$199K | 0.07% | 263 |
|
|
2016
Q1 | $3.69M | Sell |
36,840
-6,232
| -14% | -$642K | 0.08% | 221 |
|
|
2015
Q4 | $5.16M | Buy |
43,072
+1
| +0% | +$116 | 0.12% | 155 |
|
|
2015
Q3 | $4.66M | Sell |
43,071
-2,802
| -6% | -$348K | 0.13% | 146 |
|
|
2015
Q2 | $5.31M | Buy |
45,873
+1,420
| +3% | +$162K | 0.15% | 145 |
|
|
2015
Q1 | $5.13M | Sell |
44,453
-1,019
| -2% | -$122K | 0.15% | 145 |
|
|
2014
Q4 | $5.09M | Buy |
45,472
+2,581
| +6% | +$272K | 0.16% | 128 |
|
|
2014
Q3 | $4.07M | Buy |
42,891
+11,571
| +37% | +$1.04M | 0.12% | 166 |
|
|
2014
Q2 | $2.69M | Buy |
31,320
+1,578
| +5% | +$120K | 0.09% | 214 |
|
|
2014
Q1 | $2.08M | Buy |
29,742
+6,274
| +27% | +$497K | 0.08% | 248 |
|
|
2013
Q4 | $1.98M | Buy |
23,468
+1,080
| +5% | +$85.5K | 0.08% | 236 |
|
|
2013
Q3 | $1.73M | Buy |
22,388
+2,124
| +10% | +$149K | 0.08% | 248 |
|
|
2013
Q2 | $1.19M | Buy |
+20,264
| New | +$1.22M | 0.06% | 284 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Cambridge Investment Research Advisors's CELG Position: Q4 2019 in Review
Cambridge Investment Research Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 140,331 shares — an estimated $13.9M sold.
Cambridge Investment Research Advisors first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $13.9M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Cambridge Investment Research Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Cambridge Investment Research Advisors sold 140,331 Celgene Corp shares in Q4 2019, an estimated $13.9M.
- Cambridge Investment Research Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Cambridge Investment Research Advisors's Celgene Corp position peaked at $13.9M in Q3 2019.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Cambridge Investment Research Advisors's 13F filing for Q4 2019, filed 4 Feb 2020.